Fennec Pharmaceuticals Inc (FRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,650 | 22,781 | 28,260 | 3,926 | 942 |
| Other current assets | 8 | 1 | 13 | 3 | 1 |
| TOTAL | $13,884 | $22,950 | $28,401 | $3,972 | $1,019 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 262 | 0 | 0 | 0 | 0 |
| TOTAL | $262 | $0 | $0 | $0 | $0 |
| Total Assets | $14,146 | $22,950 | $28,401 | $3,972 | $1,019 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,612 | 1,032 | 855 | 244 | 297 |
| Accrued Expenses | 659 | 605 | 622 | 125 | 92 |
| Other current liabilities | N/A | N/A | 167 | 33 | 82 |
| TOTAL | $2,271 | $1,637 | $1,644 | $402 | $471 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,271 | $1,637 | $1,644 | $402 | $471 |
| Shareholders' Equity | |||||
| Common Shares | 106,392 | 106,392 | 103,045 | 74,515 | 69,153 |
| Retained earnings | -144,031 | -131,256 | -121,368 | -114,322 | -111,533 |
| Other shareholders' equity | 1,243 | 1,243 | 1,243 | 1,243 | 1,243 |
| TOTAL | $11,875 | $21,313 | $26,757 | $3,570 | $548 |
| Total Liabilities And Equity | $14,146 | $22,950 | $28,401 | $3,972 | $1,019 |